Results 81 to 90 of about 750,552 (306)

Apixaban versus warfarin in patients with atrial fibrillation.

New England Journal of Medicine, 2011
BACKGROUND Vitamin K antagonists are highly effective in preventing stroke in patients with atrial fibrillation but have several limitations. Apixaban is a novel oral direct factor Xa inhibitor that has been shown to reduce the risk of stroke in a ...
Christopher B Granger, J. Alexander, John J.V. McMurray, R. Lopes, E. Hylek, M. Hanna, H. Al-Khalidi, J. Ansell, D. Atar, Á. Avezum, M. Bahit, Rafael Diaz, J. Donald Easton, J. Ezekowitz, Greg C. Flaker, David A. Garcia, M. Geraldes, B. Gersh, S. Golitsyn, S. Goto, A. Hermosillo, S. Hohnloser, John D. Horowitz, Puneet Mohan, P. Janský, Basil S. Lewis, J. López-Sendón, P. Pais, A. Parkhomenko, F. Verheugt, Jun Zhu, L. Wallentin   +31 more
semanticscholar   +1 more source

Incidence, duration, pattern, and burden of de novo atrial arrhythmias detected by continuous ECG monitoring using an implantable loop recorder following ablation of the cavotricuspid isthmus

Cardiovascular Digital Health Journal, 2020
Background: Following cavotricuspid isthmus (CTI) ablation, many patients with atrial flutter (AFL) are diagnosed with atrial fibrillation (AF). The incidence, duration, pattern, and burden of AF remain undefined.
Dan L. Musat, MD, Nicolle S. Milstein, MS, Jacqueline Pimienta, MBS, Advay Bhatt, MD, FHRS, Mark W. Preminger, MD, Tina C. Sichrovsky, MD, Laura Flynn, APN, Carissa Pistilli, APN, Richard E. Shaw, PhD, Suneet Mittal, MD, FHRS   +9 more
doaj  

Glycemic control is associated with atrial structural remodeling in patients with type 2 diabetes

BMC Cardiovascular Disorders, 2019
Background Diabetes mellitus (DM) has been demonstrated to be a strong risk factor for development and perpetuation of atrial fibrillation (AF). However, how DM and glycemic control affect the pathogenesis of AF has not been sufficiently investigated ...
Qing Wang, Jing Wang, Pei Wang, Liaoyuan Wang, Lanting Jia, Xinyu Ling, Wang Xi, Jie Min, Hua Shen, Jian Xiao, Jinxiang Yuan, Zhinong Wang   +11 more
doaj   +1 more source

The effect of tyrosine residues on α-synuclein fibrillation

Acta Chimica Slovenica, 2015
Aggregation of the intrinsically disordered protein α-synuclein into ordered amyloid fibrils is implicated in the pathogenesis of Parkinson’s disease.
Katja Pirc, Miha Škarabot, Lea Pogačnik, Eva Žerovnik, natasa poklar ulrih   +4 more
doaj   +1 more source

Comparative performance of CHA2DS2VASc and anticoagulation and risk factors in atrial fibrillation risk scores for predicting mortality in patients with COVID-19

International Journal of the Cardiovascular Academy, 2021
Background: The AnTicoagulation and Risk factors in Atrial fibrillation (ATRIA) and CHA2DS2VASc risk scores used to detect the thromboembolic and hemorrhagic risk in atrial fibrillation (AF) patients has been shown recently to predict poor clinical ...
Dilay Karabulut, Ersan Oflar
doaj   +1 more source

Nucleation of amyloid fibrils [PDF]

J. Chem. Phys. 132, 215101 (2010), 2010
We consider nucleation of amyloid fibrils in the case when the process occurs by the mechanism of direct polymerization of practically fully extended protein segments, i.e. beta-strands, into beta-sheets. Applying the classical nucleation theory, we derive a general expression for the work to form a nanosized amyloid fibril (protofilament) constituted ...
arxiv   +1 more source

A Review of Atrial Fibrillation Detection Methods as a Service [PDF]

, 2020
Atrial Fibrillation (AF) is a common heart arrhythmia that often goes undetected, and even if it is detected, managing the condition may be challenging. In this paper, we review how the RR interval and Electrocardiogram (ECG) signals, incorporated into a
Acharya, U. Rajendra, Ciaccio, Edward J., Faust, Oliver   +2 more
core   +1 more source

My atrial fibrillation is not your atrial fibrillation [PDF]

European Heart Journal, 2017
Abstract not available ; Paulus Kirchhof and Prashanthan ...
Paulus Kirchhof, Paulus Kirchhof, Prashanthan Sanders   +2 more
openaire   +4 more sources

A comparison of rate control and rhythm control in patients with atrial fibrillation.

New England Journal of Medicine, 2002
BACKGROUND There are two approaches to the treatment of atrial fibrillation: one is cardioversion and treatment with antiarrhythmic drugs to maintain sinus rhythm, and the other is the use of rate-controlling drugs, allowing atrial fibrillation to ...
D. Wyse, A. Waldo, J. Dimarco, M. Domanski, Y. Rosenberg, Eleanor Schron, J. Kellen, H. Greene, M. Mickel, J. Dalquist, S. Corley   +10 more
semanticscholar   +1 more source

Impaired Cardiac AMPK (5′‐Adenosine Monophosphate‐Activated Protein Kinase) and Ca2+‐Handling, and Action Potential Duration Heterogeneity in Ibrutinib‐Induced Ventricular Arrhythmia Vulnerability

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background We recently demonstrated that acute administration of ibrutinib, a Bruton's tyrosine kinase inhibitor used in chemotherapy for blood malignancies, increases ventricular arrhythmia (VA) vulnerability.
Yanan Zhao, Beibei Du, Praloy Chakraborty, Nathan Denham, Stéphane Massé, Patrick F.H. Lai, Mohammed Ali Azam, Filio Billia, Paaladinesh Thavendiranathan, Husam Abdel‐Qadir, Gary D. Lopaschuk, Kumaraswamy Nanthakumar   +11 more
doaj   +1 more source